# Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System

> **NCT00546598** · PHASE4 · TERMINATED · sponsor: **DePuy Orthopaedics** · enrollment: 106 (actual)

## Conditions studied

- Non-inflammatory Joint Disease
- Osteoarthritis
- Avascular Necrosis
- Congenital Hip Dysplasia
- Post-traumatic Arthritis

## Interventions

- **DEVICE:** Total hip replacement/arthroplasty

## Key facts

- **NCT ID:** NCT00546598
- **Lead sponsor:** DePuy Orthopaedics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-01-01
- **Primary completion:** 2014-04-01
- **Final completion:** 2014-04-01
- **Target enrollment:** 106 (ACTUAL)
- **Why stopped:** Sponsor withdrew PMA
- **Last updated:** 2021-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00546598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00546598, "Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00546598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*